Cargando…
The Neutralizing Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 and the Cytokine/Chemokine Release in Patients with Different Levels of Coronavirus Diseases 2019 Severity: Cytokine Storm Still Persists Despite Viral Disappearance in Critical Patients
Patients with coronavirus disease 2019 (COVID-19) exhibit a wide clinical spectrum ranging from mild respiratory symptoms to critical and fatal diseases, and older individuals are known to be more severely affected. The underlying mechanism of this phenomenon is unknown. A neutralizing antibody agai...
Autores principales: | Tjan, Lidya Handayani, Nagano, Tatsuya, Furukawa, Koichi, Nishimura, Mitsuhiro, Arii, Jun, Fujinaka, Sayo, Iwata, Sachiyo, Sano, Shigeru, Tohma, Yoshiki, Nishimura, Yoshihiro, Mori, Yasuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872782/ https://www.ncbi.nlm.nih.gov/pubmed/33575497 http://dx.doi.org/10.31662/jmaj.2020-0083 |
Ejemplares similares
-
Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019
por: Tjan, Lidya Handayani, et al.
Publicado: (2021) -
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan
por: Furukawa, Koichi, et al.
Publicado: (2021) -
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
por: Furukawa, Koichi, et al.
Publicado: (2022) -
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections
por: Kurahashi, Yukiya, et al.
Publicado: (2022) -
Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan
por: Furukawa, Koichi, et al.
Publicado: (2021)